MetLife, Inc. $MET Shares Purchased by Corient Private Wealth LLC

Corient Private Wealth LLC raised its holdings in MetLife, Inc. (NYSE:MET) by 4.4% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 611,606 shares of the financial services provider’s stock after buying an additional 25,877 shares during the quarter. Corient Private Wealth LLC’s holdings in MetLife were worth $48,284,000 at the end of the most recent quarter.

Other institutional investors have also recently added to or reduced their stakes in the company. Nordea Investment Management AB lifted its holdings in shares of MetLife by 2.6% during the 4th quarter. Nordea Investment Management AB now owns 4,630,165 shares of the financial services provider’s stock valued at $366,524,000 after acquiring an additional 117,545 shares in the last quarter. Lansforsakringar Fondforvaltning AB publ grew its stake in shares of MetLife by 6.5% in the third quarter. Lansforsakringar Fondforvaltning AB publ now owns 187,358 shares of the financial services provider’s stock valued at $15,433,000 after buying an additional 11,469 shares in the last quarter. Strs Ohio raised its holdings in shares of MetLife by 16.6% during the 4th quarter. Strs Ohio now owns 326,091 shares of the financial services provider’s stock valued at $25,742,000 after buying an additional 46,469 shares during the period. Lighthouse Investment Partners LLC acquired a new position in MetLife during the 3rd quarter worth approximately $8,091,000. Finally, AIA Group Ltd boosted its holdings in MetLife by 93.5% in the 3rd quarter. AIA Group Ltd now owns 33,714 shares of the financial services provider’s stock worth $2,777,000 after acquiring an additional 16,288 shares during the period. Hedge funds and other institutional investors own 94.99% of the company’s stock.

MetLife Stock Up 0.2%

MET stock opened at $85.76 on Monday. The firm has a market cap of $55.18 billion, a price-to-earnings ratio of 16.62, a PEG ratio of 0.64 and a beta of 0.78. MetLife, Inc. has a 1-year low of $67.33 and a 1-year high of $89.62. The firm has a fifty day moving average price of $81.04 and a two-hundred day moving average price of $77.78. The company has a debt-to-equity ratio of 0.53, a current ratio of 0.20 and a quick ratio of 0.20.

MetLife (NYSE:MET) last posted its quarterly earnings results on Wednesday, May 6th. The financial services provider reported $2.42 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.27 by $0.15. MetLife had a net margin of 4.66% and a return on equity of 22.60%. The company had revenue of $14.18 billion for the quarter, compared to the consensus estimate of $19.49 billion. During the same period last year, the firm posted $1.96 EPS. The company’s revenue for the quarter was up 2.7% on a year-over-year basis. Research analysts predict that MetLife, Inc. will post 9.98 EPS for the current year.

MetLife Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, June 9th. Shareholders of record on Tuesday, May 12th were issued a $0.5925 dividend. This is an increase from MetLife’s previous quarterly dividend of $0.57. This represents a $2.37 dividend on an annualized basis and a yield of 2.8%. The ex-dividend date of this dividend was Tuesday, May 12th. MetLife’s dividend payout ratio is 45.93%.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on the stock. Wells Fargo & Company boosted their target price on shares of MetLife from $90.00 to $95.00 and gave the stock an “overweight” rating in a research report on Tuesday, May 12th. Piper Sandler lifted their price target on shares of MetLife from $81.00 to $86.00 and gave the stock a “neutral” rating in a research note on Tuesday, May 26th. Evercore set a $96.00 price objective on shares of MetLife in a research report on Thursday, April 9th. Keefe, Bruyette & Woods raised their target price on MetLife from $87.00 to $98.00 and gave the company an “outperform” rating in a research note on Wednesday, May 13th. Finally, JPMorgan Chase & Co. lifted their target price on MetLife from $95.00 to $96.00 and gave the stock an “overweight” rating in a research report on Tuesday, May 12th. One equities research analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and two have given a Hold rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $95.31.

MetLife Profile

MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.

In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.